🇺🇸 FDA
Patent

US 11504385

Proteolysis targeting chimeric molecule, preparation method, and application

granted A61KA61K31/506A61K31/655

Quick answer

US patent 11504385 (Proteolysis targeting chimeric molecule, preparation method, and application) held by CHINA PHARMACEUTICAL UNIVERSITY expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CHINA PHARMACEUTICAL UNIVERSITY
Grant date
Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/506, A61K31/655, A61K41/0023, A61K47/54